Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.79% | $4.43M | €438.14B | 72.70% | 76 Outperform | |
| Roche Holding AG | 2.23% | $2.61M | CHF272.90B | 26.73% | 73 Outperform | |
| Novartis AG | 2.20% | $2.57M | CHF234.59B | 22.14% | 80 Outperform | |
| AstraZeneca | 2.10% | $2.46M | $301.48B | 20.11% | 80 Outperform | |
| HSBC Holdings | 2.07% | $2.42M | £213.83B | 42.06% | 80 Outperform | |
| Nestlé SA | 1.89% | $2.21M | CHF202.95B | 0.58% | 71 Outperform | |
| Shell (UK) | 1.75% | $2.05M | £176.52B | 22.65% | 73 Outperform | |
| SAP SE | 1.49% | $1.74M | €196.68B | -32.79% | 66 Neutral | |
| Siemens | 1.39% | $1.62M | €171.36B | -4.46% | 74 Outperform | |
| Banco Santander | 1.19% | $1.39M | €140.60B | 59.23% | 73 Outperform |